Chemogenomics: Difference between revisions
No edit summary |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Chemogenomics''' can be defined as a [[genomics|genomic]] response to [[chemical compound]]s. The goal is the rapid identification of novel [[drug]]s and [[drug target]]s embracing multiple early phase [[drug development|drug discovery]] technologies ranging from target identification and validation, over compound design and [[chemical synthesis]] to biological testing and [[ADME]] profiling. | '''Chemogenomics''' can be defined as a [[genomics|genomic]] response to [[chemical compound]]s. The goal is the rapid identification of novel [[drug]]s and [[drug target]]s embracing multiple early phase [[drug development|drug discovery]] technologies ranging from target identification and validation, over compound design and [[chemical synthesis]] to biological testing and [[ADME]] profiling. | ||
| Line 24: | Line 24: | ||
{{Medicinal chemistry}} | {{Medicinal chemistry}} | ||
{{genomics-footer}} | {{genomics-footer}} | ||
[[Category:Genomics]] | [[Category:Genomics]] | ||
Latest revision as of 23:44, 8 August 2012
|
WikiDoc Resources for Chemogenomics |
|
Articles |
|---|
|
Most recent articles on Chemogenomics Most cited articles on Chemogenomics |
|
Media |
|
Powerpoint slides on Chemogenomics |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Chemogenomics at Clinical Trials.gov Trial results on Chemogenomics Clinical Trials on Chemogenomics at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Chemogenomics NICE Guidance on Chemogenomics
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Chemogenomics Discussion groups on Chemogenomics Patient Handouts on Chemogenomics Directions to Hospitals Treating Chemogenomics Risk calculators and risk factors for Chemogenomics
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Chemogenomics |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Chemogenomics can be defined as a genomic response to chemical compounds. The goal is the rapid identification of novel drugs and drug targets embracing multiple early phase drug discovery technologies ranging from target identification and validation, over compound design and chemical synthesis to biological testing and ADME profiling.
See also
References
- Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, H. Kubinyi (Editor), G. Müller (Editor), R. Mannhold (Series Editor), G. Folkers (Series Editor), Wiley-VCH, 2004.ISBN 3-527-30987-X
External links
Template:Medicinal chemistry Template:Genomics-footer ko:화학유전체학